migraine with aura
Information
- Disease name
- migraine with aura
- Disease ID
- DOID:10024
- Description
- "A migraine characterized by migraine headache which is preceded or accompanied by a transient focal neurological phenomenon." [url:http\://en.wikipedia.org/wiki/Migraine, url:http\://www.mayoclinic.org/diseases-conditions/migraine-with-aura/basics/definition/con-20030404]
Disease area statistics
[No Data.]
Chromosome band
[No Data.]
Annotation
| Genes | Mutation | Description | Source | Links |
|---|
| NCT ID | Status | Phase | Summary | Start date | Completion date |
|---|---|---|---|---|---|
| NCT03301441 | Active, not recruiting | Sensitivity to Acute Cerebral Ischemia in Migrainers | February 9, 2018 | July 2024 | |
| NCT00311662 | Completed | Phase 2 | Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache | April 2006 | October 2006 |
| NCT00332007 | Completed | Phase 2 | Tonabersat in the Prophylaxis of Migraine With Aura | May 2006 | August 2008 |
| NCT00334178 | Completed | Phase 3 | Evaluation of the Efficacy and Safety of Laxymig® as Prophylactic Treatment in Patients With Migraine | November 2004 | September 2006 |
| NCT00449540 | Completed | Phase 3 | Efficacy and Safety of TMS for the Preemptive Treatment of Migraine With Aura | August 2006 | March 2008 |
| NCT00471952 | Completed | Phase 3 | Maxalt 10mg Plus Caffeine 75mg in the Acute Treatment of Migraine Headache | April 2007 | April 2008 |
| NCT00123201 | Completed | Phase 2 | Study to Evaluate the Efficacy and Safety of Dronabinol Metered Dose Inhaler (MDI) in Acute Treatment of Migraine Headache | September 2005 | March 2007 |
| NCT00534560 | Completed | Phase 2 | Dose Ranging Study of the Efficacy and Tolerability of Tonabersat in the Prophylaxis of Migraine Headache | October 2007 | March 2009 |
| NCT00687947 | Completed | N/A | Calcitonin Gene-related Peptide in Familial Hemiplegic Migraine (FHM) and Migraine With Aura (MA) | May 2008 | August 2008 |
| NCT00884663 | Completed | Phase 2/Phase 3 | Candesartan Versus Propranolol for Migraine Prevention | April 2009 | March 2012 |
| NCT00920686 | Completed | Phase 2 | Study of NXN 188 for the Treatment of Migraine With Aura | June 2009 | March 2010 |
| NCT01257880 | Completed | Comorbidities Associated With Migraine and Patent Foramen Ovale (CAMP) | January 2010 | May 2011 | |
| NCT01388699 | Completed | Migraine and Endothelial Dysfunction | October 2010 | December 2011 | |
| NCT01596166 | Completed | Phase 4 | Intravenous Ketorolac and Metoclopramide for Pediatric Migraine in the Emergency Department | February 2012 | April 2014 |
| NCT01741714 | Completed | N/A | Is Chiropractic Spinal Manipulative Therapy an Efficient Treatment Option for Migraine | February 2013 | September 2015 |
| NCT01804517 | Completed | Impact of a Nurse for Migraine Management: the IMPACT Project | February 2013 | November 2015 | |
| NCT01814189 | Completed | Phase 3 | Efficacy and Safety of Oral Sumatriptan Plus Oral Promethazine in Migraine Treatment | January 2013 | April 2013 |
| NCT01859481 | Completed | Phase 3 | Eletriptan Provides Consistent Migraine Relief: Results Of A Within-Patient Multiple-Dose Study | March 2000 | March 2002 |
| NCT01865604 | Completed | N/A | Impact of tDCS on Cerebral Autoregulation | April 2012 | March 2014 |
| NCT02047695 | Completed | Women With Migraine With Aura Neuroimaging Study | February 2011 | April 2017 | |
| NCT02115269 | Completed | IndoProCaf Effervescent Tablets Effectiveness in Acute Treatment of Migraine and/or Episodic Tension-type Headache and Patients' Satisfaction With the Treatment in Routine Clinical Practice | June 2014 | November 2015 | |
| NCT02253004 | Completed | Early Phase 1 | Induction of Migraine Aura With Cilostazol | September 2014 | August 2015 |
| NCT02708797 | Completed | N/A | Brainstem Grey Matter and Cerebral Autoregulation in Migraine With Aura. | May 2016 | April 2017 |
| NCT02795351 | Completed | Early Phase 1 | Induction of Migraine Aura With Sildenafil | June 2015 | August 2021 |
| NCT03177616 | Completed | N/A | Integrative Migraine Pain Alleviation Through Chiropractic Therapy | June 7, 2017 | November 4, 2022 |
| NCT03361423 | Completed | N/A | Evaluation of a Novel Device for Treatment of Migraine Headache | December 17, 2017 | December 25, 2018 |
| NCT03472378 | Completed | Phase 2 | Can DFN-15 Terminate Migraine With Allodynia? | May 9, 2018 | April 12, 2019 |
| NCT03472417 | Completed | N/A | Partial Rebreathing in the Treatment of Migraine With Aura | November 2016 | September 2017 |
| NCT03479060 | Completed | N/A | Continue or Stop Applying Wet Cupping (Al-Hijamah) in Migraine | January 3, 2017 | March 1, 2018 |
| NCT03521193 | Completed | N/A | pLatelEts And MigRaine iN patEnt foRamen Ovale | February 15, 2018 | October 31, 2020 |
| NCT03536936 | Completed | Oxygenation and Perfusion in Patients With Acute Migraine Attacks | January 1, 2010 | April 30, 2018 | |
| NCT03874832 | Completed | Phase 1 | A Phase I Study to Study the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy Subjects | September 11, 2018 | November 7, 2018 |
| NCT03901482 | Completed | Phase 3 | A Randomized, Double-Blind, Placebo-Controlled Study to Evaluate STS101 in the Acute Treatment of Migraine | June 24, 2019 | August 13, 2020 |
| NCT04171362 | Completed | N/A | The Effect of Connective Tissue Massage in Patients With Migraine | March 28, 2019 | December 20, 2019 |
| NCT04406649 | Completed | Phase 3 | A Study to Evaluate the Safety of STS101 in the Acute Treatment of Migraine | September 14, 2020 | January 16, 2023 |
| NCT04940390 | Completed | Phase 3 | A Randomized, Double-Blind, Parallel Group, Placebo-Controlled Study to Assess STS101 in the Acute Treatment of Migraine | June 30, 2021 | October 26, 2022 |
| NCT04968093 | Completed | N/A | Mindfulness for Adolescents for CM and HFEM | January 2016 | January 2021 |
| NCT05018572 | Completed | N/A | Digital Treatment for Migraines - a Feasibility Study | July 1, 2021 | October 14, 2022 |
| NCT05337254 | Completed | Phase 1 | A Study of the PK and Safety of Single Doses of STS101, DHE Injection and Nasal Spray in Healthy Subjects | March 5, 2021 | June 4, 2021 |
| NCT06023953 | Completed | Migraine With and Without Aura Response to Remote Electrical Neuromodulation (REN) Treatment | July 1, 2023 | August 1, 2023 | |
| NCT05617339 | Not yet recruiting | N/A | Tailored Digital Treatment for Migraine | January 1, 2023 | December 31, 2025 |
| NCT05484349 | Not yet recruiting | Phase 3 | TIzanidine for the Preventive Treatment of Episodic MigrainE （TIME） | August 31, 2023 | December 25, 2024 |
| NCT04373330 | Not yet recruiting | N/A | Healthy Living Partnerships for Veterans With Migraine | June 2024 | December 2024 |
| NCT06459635 | Recruiting | Migraine Attack Pain Phase Prediction Study | October 9, 2023 | December 2025 | |
| NCT05889624 | Recruiting | N/A | Responding With Evidence and Access for Childhood Headaches | August 22, 2023 | December 31, 2027 |
| NCT05903027 | Recruiting | Gepant treAtments: EffectIveNess and tolERability (GAINER) | June 15, 2023 | June 2024 | |
| NCT05903040 | Recruiting | Ditan Acute tReatments: Effectiveness and Tolerability (DART) | June 15, 2023 | June 2024 | |
| NCT06051604 | Recruiting | N/A | Mi-Helper Transnasal Cooling for Acute Treatment of Migraine | November 15, 2023 | March 2025 |
| NCT06244823 | Recruiting | Phase 4 | The FreMRI Study: Advanced MRI on Migraine Patients Treated With Fremanezumab | March 1, 2023 | January 1, 2025 |
| NCT04715685 | Recruiting | N/A | Mind Body Balance for Pediatric Migraine | March 9, 2021 | May 31, 2025 |
| NCT04726592 | Recruiting | Phase 3 | Efficacy of CLORazepate for the Treatment of MIGraine Attack in the Emergency Room | July 8, 2021 | December 1, 2024 |
| NCT06267664 | Recruiting | Real-world Effectiveness and Tolerability of Triptans-Ditans-Gepants (TRIDIGEP) | December 4, 2023 | December 1, 2024 | |
| NCT06409832 | Recruiting | RimegepAnt effectIvenesS and tolErability as Migraine Preventive Treatment | March 26, 2024 | January 2026 | |
| NCT06409845 | Recruiting | Effectiveness and Tolerability of Eptinezumab | March 26, 2024 | April 2026 | |
| NCT05211154 | Recruiting | Phase 4 | Evaluation of the Efficacy of Diclofenac Potassium and Rimegepant for the Acute Treatment of Migraine | May 5, 2022 | December 2025 |
| NCT05214001 | Recruiting | Phase 4 | Evaluation of the Efficacy of Almotriptan and Ubrogepant for the Acute Treatment of Migraine | June 30, 2022 | December 2025 |
| NCT05281770 | Recruiting | Monoclonal CGRP Antibodies for Migraine Prevention - a Nationwide Real Life Study | October 1, 2022 | December 1, 2025 | |
| NCT06414044 | Recruiting | Italian Real-life obServational Study on the effecTiveness, sAfety and Tolerability of Atogepant in Migraine Patients | May 9, 2024 | April 2026 | |
| NCT05416476 | Recruiting | Phase 3 | Anisodine Hydrobromide For The Preventive Treatment Of Episodic Migraine | October 30, 2023 | December 31, 2025 |
| NCT05546385 | Recruiting | N/A | PArtial REbreathing for Migraine With Aura 1 | June 16, 2023 | October 2025 |
| NCT05565001 | Recruiting | N/A | The Involvement of ATP Sensitive Potassium Channel in Migraine Aura and Migraine Pain. | September 1, 2022 | July 31, 2023 |
| NCT00505570 | Terminated | Phase 2 | PRIMA PFO Migraine Trial | May 2006 | February 2013 |
| NCT04936061 | Terminated | N/A | Transnasal Cooling for Migraine | October 14, 2021 | September 30, 2022 |
| NCT00739024 | Terminated | Phase 2 | A Study of a Melatonin Receptor Agonist to Prevent Migraine | April 2008 | September 2010 |
| NCT00893594 | Unknown status | N/A | Efficacy of Sumatriptan With Naprosyn in Migraine With Aura | October 2010 | December 2015 |
| NCT01319825 | Unknown status | Phase 4 | Preventive Treatment of Episodic and Chronic Migraine | April 2011 | July 2012 |
| NCT04452929 | Unknown status | N/A | The Effect of Anti-calcitonin Gene-related Peptide (CGRP) Receptor Antibodies on the Headache Inducing Properties of CGRP and Cilostazol in Migraine Patients | July 22, 2020 | July 2022 |
| NCT01388894 | Unknown status | Functional MRI and MRA in Migraine With Aura | December 2010 | ||
| NCT02202486 | Unknown status | Investigation of the Blood-brain and Blood-dura Barrier Durin Migraine Attacks Using MRI | September 2012 | December 2015 | |
| NCT00285402 | Unknown status | Phase 2 | Efficacy and Safety Clinical Trial of Intranasal AST-726 for the Prevention of Migraine | May 2007 | June 2008 |
| NCT04063540 | Unknown status | Phase 2 | Acid-Sensing Ion Channel and Migraine Disease Proof of Concept Study on the Efficacy of Amiloride in the Prophylaxis of Migraine Aura | November 2019 | November 2021 |
| NCT00877838 | Unknown status | Phase 2 | Study of the Safety and Effectiveness of NXN-188 for the Acute Treatment of Migraine Attacks With Aura | May 2009 | December 2010 |
| NCT03143465 | Unknown status | N/A | Pharmacologically Triggered Migraine Without Aura and Neuroimaging | August 2016 | May 2019 |
| NCT02906085 | Unknown status | N/A | Endothelin-1 as a Potential Trigger of Migraine Aura | October 2016 | December 2019 |
| NCT05332431 | Unknown status | Optical Coherence Tomography Findings in Migraine | April 2022 | June 1, 2023 | |
| NCT01653522 | Withdrawn | N/A | The Impact of Triptan and Doxycycline on Neuroinflammatory Biomarkers in Acute Migraine | July 2012 | July 2014 |
- Disase is a (Disease Ontology)
- DOID:6364
- Cross Reference ID (Disease Ontology)
- ICD10CM:G43.1
- Cross Reference ID (Disease Ontology)
- ICD9CM:346.0
- Cross Reference ID (Disease Ontology)
- MESH:D020325
- Cross Reference ID (Disease Ontology)
- MIM:609179
- Cross Reference ID (Disease Ontology)
- MIM:609670
- Cross Reference ID (Disease Ontology)
- NCI:C117005
- Cross Reference ID (Disease Ontology)
- SNOMEDCT_US_2023_03_01:155047002
- Cross Reference ID (Disease Ontology)
- UMLS_CUI:C0154723
- Exact Synonym (Disease Ontology)
- classic migraine
- HPO Human Phenotype ID (Human Phenotype Ontology)
- HP:0002077
- MedGen concept unique identifier (MedGen Concept name)
- C0154723
- MedGen unique identifier (MedGen Concept name)
- 57822
- MeSH unique ID (MeSH (Medical Subject Headings))
- D020325